Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
Date:7/30/2009

PITTSBURGH, July 30 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced its financial results for the three and six months ended June 30, 2009.

Financial Highlights

  • Adjusted diluted EPS, which excludes the impact of certain purchase accounting items as well as other non-cash and/or non-recurring items as detailed below, was $0.32 and $0.65 for the three and six months ended June 30, 2009, compared to $0.20 and $0.29 for the same prior year periods;
  • Total revenues of $1.27 billion for the three months ended June 30, 2009, an increase of $63.9 million over the same prior year period;
  • Total revenues of $2.48 billion for the six months ended June 30, 2009, an increase of $199.3 million over the same prior year period;
  • On a GAAP basis, the company reported diluted EPS of $0.19 and $0.42 for the three and six months ended June 30, 2009, compared to a loss per share of $0.05 and $1.52 in the same prior year periods. The six months ended June 30, 2008 included a non-cash goodwill impairment charge of $385.0 million related to the Specialty Segment.

Mylan's Chairman and CEO Robert J. Coury commented: "This was yet another successful quarter on many fronts for Mylan as, across the board, we delivered another quarter of financial performance that exceeded our expectations. Our powerful and integrated global platform enabled each of our businesses to generate year-over-year quarterly revenue growth on a constant currency basis and to deliver additional operational efficiencies as well. In addition, we took an important initial step in one of our targeted areas of future growth by entering into a collaborative agreement with Biocon in the area of generic biologics."


'/>"/>
SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)
2. Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market
3. Mylan Again Calls for an End to Authorized Generics During 180-Day Exclusivity Period
4. Mylan Receives Tentative FDA Approval for Generic Version of Singulair(R)
5. Mylans Matrix Selected by the Clinton HIV/AIDS Initiative and UNITAID as the Primary Supplier of Five Second-Line and Seven Pediatric HIV/AIDS Treatments
6. Mylans Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
7. Mylan Confirms Four First-to-File Challenges
8. Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
9. Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008
10. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
11. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... PUNE, India , August 28, 2015 ... Market, by Product (Media, Sera, Cryogenic Storage Systems, Thawing ... Application (Therapeutic, Regenerative Medicine, Clinical Trials), End User - ... Biopreservation Market is expected to reach USD 3,731.03 Million ... at a CAGR of 11.65% between 2015 and 2020. ...
(Date:8/28/2015)... 28, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... company focused on the development of autologous cell ... ended June 30, 2015, corporate highlights, and near-term ... are available at www.sedar.com ,  www.edgar.com ... "RepliCel expects to launch its RCS-01 treatment ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... venture capital funds, investment firms and animal health companies to hear from animal ... $160 million. Several have also received licensing agreements or distribution contracts. This ...
(Date:8/27/2015)... 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC ... Pharmaceutical Holding Company Limited (Biohaven), announced today that ... of BHV-0223, a glutamate modulating agent. Biohaven filed ... recently obtained clearance from the U.S. Food and ... Portage holds 54% equity interest in Biohaven, a ...
Breaking Biology Technology:Biopreservation Market Worth 3,731.03 Million USD by 2020 2Biopreservation Market Worth 3,731.03 Million USD by 2020 3Biopreservation Market Worth 3,731.03 Million USD by 2020 4Biopreservation Market Worth 3,731.03 Million USD by 2020 5RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4
... the course of any week, in my role as co-founder ... of CCC, I meet many interesting entrepreneurs, IT professionals, business ... events from which I desire to share my observations. I ... have some fun revisiting my experiences. My first Journal is ...
... technology are outstripping the development of new drugs ... preventing disease. Today, information networks are making it ... and advances in genetic profiling are enabling doctors ... A flagship one-day symposium, "From Fail and Fix ...
... Helping Protect Against Wireless Hacking and Rogue Access ... of the information technology industry's first comprehensive intrusion ... security breaches on wireless local area networks. ... managed security service that melds IBM Global Services' ...
Cached Biology Technology:Mr. Jackson Goes to Washington 2Mr. Jackson Goes to Washington 3Mr. Jackson Goes to Washington 4Symposium To Explore Information Technology's Impact on Improving Quality, Cost Effectiveness of Healthcare 2IBM Develops Wireless Security Service 2
(Date:8/10/2015)... Germany , August 10, 2015 /PRNewswire/ ... world leader in Eye Tracking Technology for more than ... Eye Tracking Platform for integration into all consumer display ... designs for seamless integration of eye tracking into consumer ... and augmented reality smart glasses. Omnivision,s leading sensor technology ...
(Date:8/6/2015)... Aug. 6, 2015  Today, U.S. Congressman ... Crossmatch ™ to learn firsthand how Silicon Valley ... Crossmatch is a world leader in multi-factor identity ... are helping federal agencies and commercial organizations achieve ... "The vast majority of network breaches ...
(Date:8/6/2015)... , Aug. 6, 2015 Synaptics Inc. ... human interface solutions, today announced collaboration with Microsoft ... Windows 10. Microsoft leveraged Synaptics, deep expertise in ... system. Through stringent testing, Synaptics, ... certified with Microsoft,s Precision TouchPad (PTP) specification empowering ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Rep. Honda to Visit Crossmatch in Redwood City 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... Few events involving animals are more dramatic than when ... cross-country. Among examples are the many thousands of wildebeests ... across the African plains. , Countless millions of ... with their own kind and form teeming, hungry islands ...
... components of our blood, are ancient proteins with well-known ... are also present in plants and bacteria, but until ... unclear. A group of researchers reveal this week that ... the fixation of nitrogen in the root nodules of ...
... Scientists at the U.S. Department of Energy's Brookhaven National ... in medical imaging to track the distribution of nutrients ... attack. The research provides new insights on a long-debated ... shows that radiotracer imaging can be a big help ...
Cached Biology News:Experiments provide proof of how traveling in groups protects insects 2Plant hemoglobins: Oxygen handlers critical for nitrogen fixation 2Poplar trees redirect resources in response to simulated attack 2Poplar trees redirect resources in response to simulated attack 3